nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—CSF3—liver cancer	0.05	0.0925	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—FST—liver cancer	0.0398	0.0735	CbGpPWpGaD
Carbimazole—CYP19A1—Endogenous sterols—NR1H4—liver cancer	0.0249	0.0461	CbGpPWpGaD
Carbimazole—Oropharyngeal discomfort—Sorafenib—liver cancer	0.0247	0.0537	CcSEcCtD
Carbimazole—TPO—Amino acid and derivative metabolism—TAT—liver cancer	0.0232	0.043	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—CSF2—liver cancer	0.0214	0.0396	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—HGF—liver cancer	0.0187	0.0346	CbGpPWpGaD
Carbimazole—Mouth ulceration—Sorafenib—liver cancer	0.0162	0.0353	CcSEcCtD
Carbimazole—TPO—Amino acid and derivative metabolism—GLUL—liver cancer	0.0158	0.0292	CbGpPWpGaD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.0116	0.0214	CbGpPWpGaD
Carbimazole—Neutropenia—Sorafenib—liver cancer	0.0105	0.0229	CcSEcCtD
Carbimazole—Bone marrow depression—Epirubicin—liver cancer	0.00982	0.0214	CcSEcCtD
Carbimazole—Stomatitis—Sorafenib—liver cancer	0.00978	0.0213	CcSEcCtD
Carbimazole—Jaundice—Sorafenib—liver cancer	0.00978	0.0213	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00939	0.0173	CbGpPWpGaD
Carbimazole—Bone marrow depression—Doxorubicin—liver cancer	0.00909	0.0198	CcSEcCtD
Carbimazole—TPO—Amino acid and derivative metabolism—PSMD10—liver cancer	0.00907	0.0168	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—PSMA4—liver cancer	0.00907	0.0168	CbGpPWpGaD
Carbimazole—Haemoglobin—Sorafenib—liver cancer	0.00905	0.0197	CcSEcCtD
Carbimazole—Haemorrhage—Sorafenib—liver cancer	0.00901	0.0196	CcSEcCtD
Carbimazole—TPO—Amino acid and derivative metabolism—GOT2—liver cancer	0.00883	0.0163	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—UGDH—liver cancer	0.00853	0.0158	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—VEGFA—liver cancer	0.00833	0.0154	CbGpPWpGaD
Carbimazole—Ageusia—Epirubicin—liver cancer	0.00818	0.0178	CcSEcCtD
Carbimazole—Angiopathy—Sorafenib—liver cancer	0.00817	0.0178	CcSEcCtD
Carbimazole—Alopecia—Sorafenib—liver cancer	0.00796	0.0173	CcSEcCtD
Carbimazole—CYP19A1—Tryptophan metabolism—CYP2E1—liver cancer	0.0078	0.0144	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—TGFB1—liver cancer	0.00764	0.0141	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—GOT1—liver cancer	0.00762	0.0141	CbGpPWpGaD
Carbimazole—Ageusia—Doxorubicin—liver cancer	0.00757	0.0165	CcSEcCtD
Carbimazole—Jaundice cholestatic—Epirubicin—liver cancer	0.00755	0.0164	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—MAPK14—liver cancer	0.00725	0.0134	CbGpPWpGaD
Carbimazole—Angioedema—Sorafenib—liver cancer	0.00717	0.0156	CcSEcCtD
Carbimazole—Leukopenia—Sorafenib—liver cancer	0.00702	0.0153	CcSEcCtD
Carbimazole—Jaundice cholestatic—Doxorubicin—liver cancer	0.00698	0.0152	CcSEcCtD
Carbimazole—Myalgia—Sorafenib—liver cancer	0.00668	0.0145	CcSEcCtD
Carbimazole—Arthralgia—Sorafenib—liver cancer	0.00668	0.0145	CcSEcCtD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—IL6—liver cancer	0.00666	0.0123	CbGpPWpGaD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00663	0.0144	CcSEcCtD
Carbimazole—Hepatocellular injury—Epirubicin—liver cancer	0.00663	0.0144	CcSEcCtD
Carbimazole—Infection—Sorafenib—liver cancer	0.00636	0.0139	CcSEcCtD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.00631	0.0117	CbGpPWpGaD
Carbimazole—Nervous system disorder—Sorafenib—liver cancer	0.00628	0.0137	CcSEcCtD
Carbimazole—Thrombocytopenia—Sorafenib—liver cancer	0.00627	0.0137	CcSEcCtD
Carbimazole—Aplastic anaemia—Epirubicin—liver cancer	0.00622	0.0136	CcSEcCtD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.00622	0.0115	CbGpPWpGaD
Carbimazole—Skin disorder—Sorafenib—liver cancer	0.00622	0.0135	CcSEcCtD
Carbimazole—Hepatocellular injury—Doxorubicin—liver cancer	0.00613	0.0134	CcSEcCtD
Carbimazole—Mouth ulceration—Epirubicin—liver cancer	0.00599	0.0131	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00583	0.0127	CcSEcCtD
Carbimazole—Aplastic anaemia—Doxorubicin—liver cancer	0.00576	0.0125	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—IL6—liver cancer	0.00576	0.0106	CbGpPWpGaD
Carbimazole—CYP19A1—Tryptophan metabolism—CYP1A1—liver cancer	0.0056	0.0104	CbGpPWpGaD
Carbimazole—Mouth ulceration—Doxorubicin—liver cancer	0.00555	0.0121	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—RAF1—liver cancer	0.00528	0.00975	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—MTOR—liver cancer	0.00515	0.00952	CbGpPWpGaD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.00511	0.00945	CbGpPWpGaD
Carbimazole—Urticaria—Sorafenib—liver cancer	0.00508	0.0111	CcSEcCtD
Carbimazole—Body temperature increased—Sorafenib—liver cancer	0.00506	0.011	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—NR1H4—liver cancer	0.00499	0.00921	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GSTA3—liver cancer	0.0049	0.00906	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTA3—liver cancer	0.00483	0.00893	CbGpPWpGaD
Carbimazole—TPO—Metabolism—UGDH—liver cancer	0.00479	0.00885	CbGpPWpGaD
Carbimazole—Hypersensitivity—Sorafenib—liver cancer	0.00472	0.0103	CcSEcCtD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.00453	0.00837	CbGpPWpGaD
Carbimazole—Pruritus—Sorafenib—liver cancer	0.00453	0.00987	CcSEcCtD
Carbimazole—TPO—Metabolism—EPT1—liver cancer	0.0045	0.00832	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GSTA4—liver cancer	0.00448	0.00828	CbGpPWpGaD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.00447	0.00826	CbGpPWpGaD
Carbimazole—Liver function test abnormal—Epirubicin—liver cancer	0.00444	0.00968	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTA4—liver cancer	0.00442	0.00817	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GSTA2—liver cancer	0.00437	0.00807	CbGpPWpGaD
Carbimazole—TPO—Metabolism—TAT—liver cancer	0.00427	0.00789	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AHR—liver cancer	0.00423	0.00782	CbGpPWpGaD
Carbimazole—CYP19A1—Ovarian Infertility Genes—CDKN1B—liver cancer	0.00422	0.0078	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GSTA1—liver cancer	0.00421	0.00779	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—NAT2—liver cancer	0.00417	0.0077	CbGpPWpGaD
Carbimazole—Eosinophilia—Epirubicin—liver cancer	0.00412	0.00897	CcSEcCtD
Carbimazole—Liver function test abnormal—Doxorubicin—liver cancer	0.00411	0.00896	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—NAT2—liver cancer	0.00411	0.0076	CbGpPWpGaD
Carbimazole—Rash—Sorafenib—liver cancer	0.00404	0.00879	CcSEcCtD
Carbimazole—Dermatitis—Sorafenib—liver cancer	0.00403	0.00879	CcSEcCtD
Carbimazole—Headache—Sorafenib—liver cancer	0.00401	0.00874	CcSEcCtD
Carbimazole—Pancytopenia—Epirubicin—liver cancer	0.00395	0.00861	CcSEcCtD
Carbimazole—Neutropenia—Epirubicin—liver cancer	0.00389	0.00847	CcSEcCtD
Carbimazole—Eosinophilia—Doxorubicin—liver cancer	0.00381	0.0083	CcSEcCtD
Carbimazole—Nausea—Sorafenib—liver cancer	0.0038	0.00828	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00367	0.00679	CbGpPWpGaD
Carbimazole—Pancytopenia—Doxorubicin—liver cancer	0.00365	0.00796	CcSEcCtD
Carbimazole—Jaundice—Epirubicin—liver cancer	0.00361	0.00788	CcSEcCtD
Carbimazole—Stomatitis—Epirubicin—liver cancer	0.00361	0.00788	CcSEcCtD
Carbimazole—Neutropenia—Doxorubicin—liver cancer	0.0036	0.00784	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—GPX3—liver cancer	0.00349	0.00646	CbGpPWpGaD
Carbimazole—Agranulocytosis—Epirubicin—liver cancer	0.00346	0.00754	CcSEcCtD
Carbimazole—Haemoglobin—Epirubicin—liver cancer	0.00335	0.00729	CcSEcCtD
Carbimazole—Stomatitis—Doxorubicin—liver cancer	0.00334	0.00729	CcSEcCtD
Carbimazole—Jaundice—Doxorubicin—liver cancer	0.00334	0.00729	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—HPGDS—liver cancer	0.00333	0.00616	CbGpPWpGaD
Carbimazole—Hepatitis—Epirubicin—liver cancer	0.00333	0.00725	CcSEcCtD
Carbimazole—Haemorrhage—Epirubicin—liver cancer	0.00333	0.00725	CcSEcCtD
Carbimazole—Agranulocytosis—Doxorubicin—liver cancer	0.0032	0.00698	CcSEcCtD
Carbimazole—Haemoglobin—Doxorubicin—liver cancer	0.0031	0.00675	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00308	0.00569	CbGpPWpGaD
Carbimazole—Hepatitis—Doxorubicin—liver cancer	0.00308	0.00671	CcSEcCtD
Carbimazole—Haemorrhage—Doxorubicin—liver cancer	0.00308	0.00671	CcSEcCtD
Carbimazole—Angiopathy—Epirubicin—liver cancer	0.00302	0.00658	CcSEcCtD
Carbimazole—Alopecia—Epirubicin—liver cancer	0.00294	0.00641	CcSEcCtD
Carbimazole—TPO—Metabolism—CPT1B—liver cancer	0.0029	0.00536	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GLUL—liver cancer	0.0029	0.00536	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NR1H4—liver cancer	0.0028	0.00517	CbGpPWpGaD
Carbimazole—Angiopathy—Doxorubicin—liver cancer	0.00279	0.00609	CcSEcCtD
Carbimazole—TPO—Metabolism—GSTA3—liver cancer	0.00275	0.00508	CbGpPWpGaD
Carbimazole—Alopecia—Doxorubicin—liver cancer	0.00272	0.00593	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—CYP2E1—liver cancer	0.00272	0.00502	CbGpPWpGaD
Carbimazole—Ill-defined disorder—Epirubicin—liver cancer	0.00269	0.00586	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP2E1—liver cancer	0.00268	0.00495	CbGpPWpGaD
Carbimazole—Malaise—Epirubicin—liver cancer	0.00261	0.00569	CcSEcCtD
Carbimazole—Leukopenia—Epirubicin—liver cancer	0.00259	0.00565	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—AKT1—liver cancer	0.00257	0.00474	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTA4—liver cancer	0.00252	0.00465	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GGT1—liver cancer	0.00249	0.00461	CbGpPWpGaD
Carbimazole—Ill-defined disorder—Doxorubicin—liver cancer	0.00249	0.00542	CcSEcCtD
Carbimazole—Myalgia—Epirubicin—liver cancer	0.00247	0.00538	CcSEcCtD
Carbimazole—Arthralgia—Epirubicin—liver cancer	0.00247	0.00538	CcSEcCtD
Carbimazole—TPO—Metabolism—GSTA2—liver cancer	0.00245	0.00453	CbGpPWpGaD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00245	0.00534	CcSEcCtD
Carbimazole—Discomfort—Epirubicin—liver cancer	0.00244	0.00531	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—ABL1—liver cancer	0.00243	0.00449	CbGpPWpGaD
Carbimazole—Malaise—Doxorubicin—liver cancer	0.00242	0.00527	CcSEcCtD
Carbimazole—Leukopenia—Doxorubicin—liver cancer	0.0024	0.00523	CcSEcCtD
Carbimazole—TPO—Metabolism—GSTA1—liver cancer	0.00236	0.00437	CbGpPWpGaD
Carbimazole—Infection—Epirubicin—liver cancer	0.00235	0.00512	CcSEcCtD
Carbimazole—TPO—Metabolism—NAT2—liver cancer	0.00234	0.00432	CbGpPWpGaD
Carbimazole—Nervous system disorder—Epirubicin—liver cancer	0.00232	0.00505	CcSEcCtD
Carbimazole—Thrombocytopenia—Epirubicin—liver cancer	0.00232	0.00505	CcSEcCtD
Carbimazole—Skin disorder—Epirubicin—liver cancer	0.0023	0.00501	CcSEcCtD
Carbimazole—Arthralgia—Doxorubicin—liver cancer	0.00228	0.00497	CcSEcCtD
Carbimazole—Myalgia—Doxorubicin—liver cancer	0.00228	0.00497	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00227	0.00494	CcSEcCtD
Carbimazole—Discomfort—Doxorubicin—liver cancer	0.00226	0.00492	CcSEcCtD
Carbimazole—TPO—Metabolism—ALDOB—liver cancer	0.00224	0.00414	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GSTP1—liver cancer	0.00224	0.00414	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTP1—liver cancer	0.00221	0.00408	CbGpPWpGaD
Carbimazole—Infection—Doxorubicin—liver cancer	0.00217	0.00474	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00215	0.0047	CcSEcCtD
Carbimazole—Nervous system disorder—Doxorubicin—liver cancer	0.00215	0.00468	CcSEcCtD
Carbimazole—Thrombocytopenia—Doxorubicin—liver cancer	0.00214	0.00467	CcSEcCtD
Carbimazole—TPO—Metabolism—CRABP1—liver cancer	0.00214	0.00395	CbGpPWpGaD
Carbimazole—Skin disorder—Doxorubicin—liver cancer	0.00213	0.00463	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—GSTM1—liver cancer	0.00206	0.0038	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTM1—liver cancer	0.00203	0.00375	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00199	0.00434	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.00199	0.00367	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—CYP1A1—liver cancer	0.00195	0.00361	CbGpPWpGaD
Carbimazole—Feeling abnormal—Epirubicin—liver cancer	0.00195	0.00425	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP1A1—liver cancer	0.00192	0.00356	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00191	0.00354	CbGpPWpGaD
Carbimazole—Urticaria—Epirubicin—liver cancer	0.00188	0.00409	CcSEcCtD
Carbimazole—Body temperature increased—Epirubicin—liver cancer	0.00187	0.00407	CcSEcCtD
Carbimazole—TPO—Metabolism—HPGDS—liver cancer	0.00187	0.00345	CbGpPWpGaD
Carbimazole—Feeling abnormal—Doxorubicin—liver cancer	0.0018	0.00393	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—ESR1—liver cancer	0.00179	0.00332	CbGpPWpGaD
Carbimazole—Hypersensitivity—Epirubicin—liver cancer	0.00174	0.0038	CcSEcCtD
Carbimazole—Urticaria—Doxorubicin—liver cancer	0.00174	0.00379	CcSEcCtD
Carbimazole—Body temperature increased—Doxorubicin—liver cancer	0.00173	0.00377	CcSEcCtD
Carbimazole—Pruritus—Epirubicin—liver cancer	0.00167	0.00365	CcSEcCtD
Carbimazole—TPO—Metabolism—PSMA4—liver cancer	0.00167	0.00308	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PSMD10—liver cancer	0.00167	0.00308	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GOT2—liver cancer	0.00162	0.003	CbGpPWpGaD
Carbimazole—Hypersensitivity—Doxorubicin—liver cancer	0.00161	0.00351	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BRAF—liver cancer	0.00159	0.00295	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CDH1—liver cancer	0.00156	0.00288	CbGpPWpGaD
Carbimazole—Pruritus—Doxorubicin—liver cancer	0.00155	0.00337	CcSEcCtD
Carbimazole—TPO—Metabolism—CYP2E1—liver cancer	0.00152	0.00282	CbGpPWpGaD
Carbimazole—Rash—Epirubicin—liver cancer	0.00149	0.00325	CcSEcCtD
Carbimazole—Dermatitis—Epirubicin—liver cancer	0.00149	0.00325	CcSEcCtD
Carbimazole—Headache—Epirubicin—liver cancer	0.00148	0.00323	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.00146	0.00271	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—UGDH—liver cancer	0.00146	0.0027	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYCS—liver cancer	0.00143	0.00264	CbGpPWpGaD
Carbimazole—Nausea—Epirubicin—liver cancer	0.0014	0.00306	CcSEcCtD
Carbimazole—TPO—Metabolism—GGT1—liver cancer	0.0014	0.00259	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GOT1—liver cancer	0.0014	0.00259	CbGpPWpGaD
Carbimazole—Rash—Doxorubicin—liver cancer	0.00138	0.00301	CcSEcCtD
Carbimazole—Dermatitis—Doxorubicin—liver cancer	0.00138	0.003	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—EPT1—liver cancer	0.00137	0.00254	CbGpPWpGaD
Carbimazole—Headache—Doxorubicin—liver cancer	0.00137	0.00299	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—TAT—liver cancer	0.0013	0.0024	CbGpPWpGaD
Carbimazole—Nausea—Doxorubicin—liver cancer	0.0013	0.00283	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MTOR—liver cancer	0.0013	0.0024	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.00128	0.00236	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTP1—liver cancer	0.00126	0.00232	CbGpPWpGaD
Carbimazole—TPO—Metabolism—HMOX1—liver cancer	0.00124	0.00229	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CASP3—liver cancer	0.0012	0.00221	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CCND1—liver cancer	0.00116	0.00215	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—JUN—liver cancer	0.00116	0.00215	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTM1—liver cancer	0.00115	0.00213	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—liver cancer	0.00115	0.00213	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP1A1—liver cancer	0.00109	0.00202	CbGpPWpGaD
Carbimazole—TPO—Metabolism—MTHFR—liver cancer	0.00102	0.00189	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—liver cancer	0.00101	0.00187	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PPARA—liver cancer	0.001	0.00185	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000958	0.00177	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MYC—liver cancer	0.000933	0.00172	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CPT1B—liver cancer	0.000884	0.00163	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GLUL—liver cancer	0.000884	0.00163	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—KRAS—liver cancer	0.000862	0.00159	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CG—liver cancer	0.000858	0.00158	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NR1H4—liver cancer	0.000853	0.00158	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTA3—liver cancer	0.000838	0.00155	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PPARG—liver cancer	0.000828	0.00153	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTA4—liver cancer	0.000767	0.00142	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—liver cancer	0.000766	0.00142	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CD—liver cancer	0.000754	0.00139	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000749	0.00138	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTA2—liver cancer	0.000747	0.00138	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ALB—liver cancer	0.000744	0.00138	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTA1—liver cancer	0.000721	0.00133	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NAT2—liver cancer	0.000713	0.00132	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000685	0.00127	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ALDOB—liver cancer	0.000683	0.00126	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CB—liver cancer	0.000657	0.00121	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CRABP1—liver cancer	0.000652	0.0012	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—liver cancer	0.000647	0.0012	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000587	0.00108	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HPGDS—liver cancer	0.00057	0.00105	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000566	0.00105	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000516	0.000954	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000509	0.000941	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PSMA4—liver cancer	0.000508	0.000939	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PSMD10—liver cancer	0.000508	0.000939	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GOT2—liver cancer	0.000494	0.000913	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP2E1—liver cancer	0.000464	0.000858	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.00045	0.000831	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYCS—liver cancer	0.000435	0.000803	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GOT1—liver cancer	0.000426	0.000788	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GGT1—liver cancer	0.000426	0.000788	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CA—liver cancer	0.000401	0.00074	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTP1—liver cancer	0.000383	0.000708	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HMOX1—liver cancer	0.000378	0.000698	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTM1—liver cancer	0.000352	0.000651	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP1A1—liver cancer	0.000334	0.000617	CbGpPWpGaD
Carbimazole—TPO—Metabolism—AKT1—liver cancer	0.000327	0.000605	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—MTHFR—liver cancer	0.000311	0.000575	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PPARA—liver cancer	0.000305	0.000564	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000274	0.000507	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CG—liver cancer	0.000261	0.000483	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PPARG—liver cancer	0.000252	0.000466	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CD—liver cancer	0.00023	0.000425	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ALB—liver cancer	0.000227	0.000419	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CB—liver cancer	0.0002	0.00037	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CA—liver cancer	0.000122	0.000226	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AKT1—liver cancer	9.97e-05	0.000184	CbGpPWpGaD
